What's new

Human medicines European public assessment report (EPAR): Relvar Ellipta, fluticasone furoate,vilanterol, Date of authorisation: 13/11/2013, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): Relvar Ellipta, fluticasone furoate,vilanterol, Date of authorisation: 13/11/2013, Revision: 28, Status: Authorised

Apr 10, 2025 - 14:24
 0
Human medicines European public assessment report (EPAR): Relvar Ellipta, fluticasone furoate,vilanterol, Date of authorisation: 13/11/2013, Revision: 28, Status: Authorised
Human medicines European public assessment report (EPAR): Relvar Ellipta, fluticasone furoate,vilanterol, Date of authorisation: 13/11/2013, Revision: 28, Status: Authorised
Read More

Tags:

Previous Article

Alzheon's Alzheimer's drug knocked down in pivotal APOLLOE4 bout

Next Article

Comment period extended for new US alcohol labeling rules

Related Posts

EMEA-001949-PIP01-16-M06

EMEA-001949-PIP01-16-M06

Mar 14, 2025  0

PSUSA/00010184/202406

PSUSA/00010184/202406

Feb 13, 2025  0

Human medicines European public assessment report (EPAR): Jardiance, empagliflozin, Date of authorisation: 22/05/2014, Revision: 31, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 2, 2025  0